← Back to Search

Behavioral Intervention

Self-compassion intervention for Self-Compassion

N/A
Waitlist Available
Led By Robert Simpson, PhD
Research Sponsored by Robert Simpson
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up measured at baseline, 8-week follow-up, and 3-month follow-up.
Awards & highlights

Study Summary

This trial aims to study the effects of a compassion-based intervention (Mindful Self-Compassion course) on people with multiple sclerosis. The objectives include assessing the feasibility of the trial processes, exploring

Who is the study for?
This trial is for individuals with multiple sclerosis interested in exploring how a self-compassion course might affect their well-being. Participants should be willing to engage in an 8-week online course and provide feedback on their experience.Check my eligibility
What is being tested?
The study tests the Mindful Self-Compassion (MSC) course's impact on stress, anxiety, depression, emotion regulation, illness adjustment, and self-compassion in people with multiple sclerosis over eight weeks and at a three-month follow-up.See study design
What are the potential side effects?
Since this intervention involves a non-medical course focusing on mindfulness and compassion, no traditional side effects are expected. However, participants may experience emotional discomfort while reflecting on personal challenges during the course.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~measured at baseline, 8-week follow-up, and 3-month follow-up.
This trial's timeline: 3 weeks for screening, Varies for treatment, and measured at baseline, 8-week follow-up, and 3-month follow-up. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adherence
Follow-up rates
Recruitment
+1 more
Secondary outcome measures
Adjustment
Anxiety
Depression
+5 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Self-compassion interventionExperimental Treatment1 Intervention
8-week manualized online Mindful Self-Compassion course

Find a Location

Who is running the clinical trial?

Robert SimpsonLead Sponsor
Robert Simpson, PhDPrincipal InvestigatorUnity Health Toronto

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the anticipated results that this research aims to achieve?

"The primary aim of this study, with an evaluation period spanning about 4 months, is to enroll participants. Secondary objectives encompass measuring stress levels through the Perceived Stress Scale-10 where scores can fall between 0 and 40 indicating varying degrees of perceived stress; evaluating emotion regulation using the Difficulties in Emotion Regulation Scale - Short Form which employs a 5-point Likert scale to gauge challenges in managing emotions; and assessing quality of life utilizing the Multiple sclerosis Impact Scale (MSIS-29) on a Likert scale from 1 to 5 for each item with higher cumulative scores reflecting more pronounced disability."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Self-compassion for People With Multiple Sclerosis: An Exploratory Feasibility Study
Robert Simpson 2024. "Self-compassion for People With Multiple Sclerosis: An Exploratory Feasibility Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06337903.
~30 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top